Midbrain iron content in early Parkinson disease
暂无分享,去创建一个
[1] R. Brooks,et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. , 1999, Radiology.
[2] K. Earle. Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.
[3] F. Ye,et al. Increasing striatal iron content associated with normal aging , 1998, Movement disorders : official journal of the Movement Disorder Society.
[4] Jim M Wild,et al. Multiple gradient echo sequence optimized for rapid, single‐scan mapping of R 2* at high B0 , 2002, Magnetic resonance in medicine.
[5] Yoshiharu Tamakawa,et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. , 2002, AJNR. American journal of neuroradiology.
[6] B. Snow,et al. Criteria for diagnosing Parkinson's disease , 1992, Annals of neurology.
[7] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[8] F. Ye,et al. Estimation of brain iron in vivo by means of the interecho time dependence of image contrast , 1996, Magnetic resonance in medicine.
[9] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[10] P D Griffiths,et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. , 2000, Brain : a journal of neurology.
[11] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[12] R A Knight,et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. , 1999, Radiology.
[13] R. Ordidge,et al. Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla , 1994, Magnetic resonance in medicine.
[14] P. Riederer,et al. The role of iron in the basal ganglion. , 1990, Advances in neurology.
[15] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[16] John Ludbrook,et al. Multiple Inferences Using Confidence Intervals , 2000, Clinical and experimental pharmacology & physiology.
[17] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[18] P. Ryvlin,et al. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. , 1995, Archives of neurology.
[19] R. Ordidge,et al. Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.
[20] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[21] P Z Marmarelis,et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. , 1999, Magnetic resonance imaging.
[22] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.
[23] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[24] F. Ye,et al. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance , 1996, Movement disorders : official journal of the Movement Disorder Society.
[25] G. Reynolds,et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain , 2005, Journal of Neural Transmission.
[26] M. Hariz,et al. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. , 1992, Journal of neurosurgery.
[27] P. Boesiger,et al. T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.
[28] A. Morel,et al. Neurochemical organization of the human basal ganglia: Anatomofunctional territories defined by the distributions of calcium‐binding proteins and SMI‐32 , 2002, The Journal of comparative neurology.